Ligand Pharmaceuticals Net Non-Operating Interest Income Expense (Quarterly) Analysis

Ligand Pharmaceuticals, Inc. (LGND)

191.39 +2.39 (+1.26%) USD | NASDAQ | Feb 25, 16:00

191.53 +0.14 (+0.07%) After-Hours: 20:00

View Net Non-Operating Interest Income Expense (Quarterly) for LGND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial